WE ARE AN INNOVATIVE BIOTECHNOLOGY COMPANY
PK Bio is working towards developing innovative oral medicines targeting to improve the health of patients with neurodegenerative diseases.
We have a portfolio of proprietary compounds selectively targeting cell death signaling molecules implicated in neuroinflammation and neurodegeneration.
We have a series of compounds with neuroprotective and anti-neuroinflammatory indications in animal models and in preclinical stage.
Our neuroprotective technology was reviewed and ranked among top neuroprotective approaches by Foresight Science &Technology™ Company, initiated by NIH.
IDED awards PK Biosciences corporation and BodyViz under the Information Technology Joint Venture Program to develop 4D Virtual Dissection Software.
Copyright © 2020 PK Biosciences Corporation - All Rights Reserved.